PTGS2 and Parkinson disease: In addition to iNOS, COX-2 has been identified as another significant inflammatory component in the pathophysiology of Parkinson’s disease, as genetic deletion or pharmacological suppression of COX-2 reduces MPTP toxicity to dopaminergic neurons [151].